Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997-2010

• Published in: PloS one Vol. 8; no. 4; p. e61921
• Main Authors: Tseng, Hsiang-Kuang, Liu, Chang-Pan, Ho, Mao-Wang, Lu, Po-Liang, Lo, Hsiu-Jung, Lin, Yu-Hui, Cho, Wen-Long, Chen, Yee-Chun
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 17-04-2013; Public Library of Science (PLoS)
• Subjects: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents - pharmacology; Antifungal Agents - therapeutic use; Antigens; Antiparasitic agents; Biology; Child; Cirrhosis; Clinical medicine; Cryptococcosis; Cryptococcosis - drug therapy; Cryptococcosis - epidemiology; Cryptococcosis - microbiology; Cryptococcosis - mortality; Cryptococcus; Cryptococcus neoformans; Cryptococcus neoformans - drug effects; Cryptococcus neoformans - genetics; Cryptococcus neoformans - isolation & purification; Deoxyribonucleic acid; DNA; DNA Fingerprinting; Epidemiology; Female; Fungal infections; Fungicides; Genotype; Genotypes; HIV; HIV infections; HIV patients; Hospitalization - statistics & numerical data; Hospitals; Humans; Infections; Infectious diseases; Internal medicine; Liver; Liver cirrhosis; Liver diseases; Male; Medical research; Medicine; Meningoencephalitis; Microbial Sensitivity Tests; Microbiology; Middle Aged; Minimum inhibitory concentration; Mortality; Multivariate analysis; Pathogens; Patient outcomes; Patients; Phylogeny; Risk analysis; Risk Factors; Studies; Taiwan - epidemiology; Treatment Outcome; Tropical environments; Young Adult; Taiwan; Vancouver Island
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0061921

Among members of Cryptococcus neoformans- Cryptococcus gattii species complex, C. neoformans is distributed worldwide whereas C. gattii is considered to be more prevalent in the subtropics and tropics including Taiwan. This nationwide study was undertaken to determine the distribution of genotypes, clinical characteristics and outcomes of 219 patients with proven cryptococcosis at 20 hospitals representative of all geographic areas in Taiwan during 1997-2010.
Of 219 isolates analyzed, C. neoformans accounted for 210 isolates (95.9%); nine isolates were C. gattii (4.1%). The predominant genotype was VNI (206 isolates). The other genotypes included VNII (4 isolates), VGI (3 isolates) and VGII (6 isolates). Antifungal minimal inhibition concentrations higher than epidemiologic cutoff values (ECVs) were found in nine VNI isolates (7 for amphotericin B). HIV infection was the most common underlying condition (54/219, 24.6%). Among HIV-negative patients, liver diseases (HBV carrier or cirrhosis) were common (30.2%) and 15.4% did not have any underlying condition. Meningoencephalitis was the most common presentation (58.9%), followed by pulmonary infection (19.6%) and "others" (predominantly cryptococcemia) (18.7%). The independent risk factors for 10-week mortality, by multivariate analysis, were cirrhosis of liver (P = 0.014) and CSF cryptococcal antigen titer ≥ 512 (P = 0.020). All except one of 54 HIV-infected patients were infected by VNI genotype (98.1%). Of the 13 isolates of genotypes other than VNI, 12 (92.3%) were isolated from HIV-negative patients. HIV-infected patients compared to HIV-negative patients were more likely to have meningoencephalitis and serum cryptococcal antigen ≥ 1:512. Patients infected with C. gattii compared to C. neoformans were younger, more likely to have meningoencephalitis (100% vs. 57%), reside in Central Taiwan (56% vs. 31%), and higher 10-week crude mortality (44.4% vs. 22.2%).
Cryptococcus neoformans in Taiwan, more prevalent than C. gatii, has a predominant VNI genotype. Isolates with antifungal MIC higher than ECVs were rare.